Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy

Journal of Heart and Lung Transplantation

Volumn 29, Issue 6, 2010, Pages 616-624

  Slaughter, Mark S ^a   Naka, Yoshifumi ^b   John, Ranjit ^c   Boyle, Andrew ^c   Conte, John V ^d   Russell, Stuart D ^d   Aaronson, Keith D ^e   Sundareswaran, Kartik S ^f   Farrar, David J ^f   Pagani, Francis D ^g  

^a University of Louisville School of Medicine   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f THORATEC CORPORATION   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

Author keywords

anticoagulation management; HeartMate II; heparin; LVAD; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN; PENTOXIFYLLINE; WARFARIN; ANTICOAGULANT AGENT;

ADULT; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEMATOCRIT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOEMBOLISM; THROMBOSIS; TREATMENT DURATION; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ADMINISTRATION; HEART TRANSPLANTATION; HEMORRHAGE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; STROKE; TIME; UNNECESSARY PROCEDURE;

ANTICOAGULANTS; ASPIRIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEMORRHAGE; HEPARIN; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; STROKE; THROMBOEMBOLISM; THROMBOSIS; TIME FACTORS; UNNECESSARY PROCEDURES; WARFARIN;

EID: 77952583879     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.02.003     Document Type: Article

References (17)

1. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
2. Frazier O.H., Rose E.A., Oz M.C., et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 122 (2001) 1186-1195
3. Miller L.W., Pagani F.D., Russell S.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357 (2007) 885-896
4. Pagani F.D., Miller L.W., Russell S.D., et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54 (2009) 312-321
5. Slaughter M.S., Rogers J.G., Milano C.A., et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361 (2009) 2241-2251
6. John R., Kamdar F., Liao K., et al. Low thromboembolic risk for patients with the HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg 136 (2008) 1318-1323
7. Boyle A.J., Russell S.D., Teuteberg J.J., et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant 28 (2009) 881-887
8. Lahpor J, Khaghani A, Hetzer R, et al. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg (in press).
9. Struber M., Sander K., Lahpor J., et al. HeartMate II left ventricular assist device; early European experience. Eur J Cardiothorac Surg 34 (2008) 289-294
10. Griffith B.P., Kormos R.L., Borovetz H.S., et al. HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg 71 suppl (2001) S116-S120
11. Maher T.R., Butler K.C., Poirier V.L., et al. HeartMate left ventricular assist devices: a multigeneration of implanted blood pumps. Artif Organs 25 (2001) 422-426
12. Kirklin J.K., Naftel D.C., Stevenson L.W., et al. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant 27 (2008) 1065-1072
13. Kaplon R.J., Gillinov A.M., Smedira N.G., et al. Vitamin K reduces bleeding in left ventricular assist device recipients. J Heart Lung Transplant 18 (1999) 346-350
14. Livingston E.R., Fisher C.A., Bibidakis E.J., et al. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation 94 (1996) II-227-II-234
15. Slaughter M.S., Sobieski M.A., Gallagher C., et al. Fibrinolytic activation during long-term support with the HeartMate II left ventricular assist device. ASAIO J 54 (2008) 115-119
16. Geisen U., Heilmann C., Beyersdorf F., et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 33 (2008) 679-684
17. Klovaite J., Gustafsson F., Mortensen S.A., et al. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol 53 (2009) 2162-2167